rs143677057

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2

The NM_002469.3(MYF6):​c.559T>A​(p.Trp187Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000646 in 1,613,308 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00065 ( 1 hom. )

Consequence

MYF6
NM_002469.3 missense

Scores

5
12
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.93
Variant links:
Genes affected
MYF6 (HGNC:7566): (myogenic factor 6) The protein encoded by this gene is a probable basic helix-loop-helix (bHLH) DNA binding protein involved in muscle differentiation. The encoded protein likely acts as a heterodimer with another bHLH protein. Defects in this gene are a cause of autosomal dominant centronuclear myopathy (ADCNM). [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP6
Variant 12-80708563-T-A is Benign according to our data. Variant chr12-80708563-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 566144.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High AC in GnomAd4 at 89 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYF6NM_002469.3 linkuse as main transcriptc.559T>A p.Trp187Arg missense_variant 2/3 ENST00000228641.4 NP_002460.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYF6ENST00000228641.4 linkuse as main transcriptc.559T>A p.Trp187Arg missense_variant 2/31 NM_002469.3 ENSP00000228641 P1

Frequencies

GnomAD3 genomes
AF:
0.000587
AC:
89
AN:
151672
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000967
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000953
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00102
Gnomad OTH
AF:
0.000959
GnomAD3 exomes
AF:
0.000660
AC:
166
AN:
251474
Hom.:
0
AF XY:
0.000647
AC XY:
88
AN XY:
135916
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00152
Gnomad NFE exome
AF:
0.00108
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000652
AC:
953
AN:
1461514
Hom.:
1
Cov.:
33
AF XY:
0.000675
AC XY:
491
AN XY:
727060
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000134
Gnomad4 ASJ exome
AF:
0.000345
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00189
Gnomad4 NFE exome
AF:
0.000735
Gnomad4 OTH exome
AF:
0.000315
GnomAD4 genome
AF:
0.000586
AC:
89
AN:
151794
Hom.:
0
Cov.:
32
AF XY:
0.000580
AC XY:
43
AN XY:
74190
show subpopulations
Gnomad4 AFR
AF:
0.0000964
Gnomad4 AMR
AF:
0.000262
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000953
Gnomad4 NFE
AF:
0.00102
Gnomad4 OTH
AF:
0.000949
Alfa
AF:
0.000733
Hom.:
1
Bravo
AF:
0.000529
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000725
AC:
88
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000654
EpiControl
AF:
0.00101

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 26, 2022The c.559T>A (p.W187R) alteration is located in exon 2 (coding exon 2) of the MYF6 gene. This alteration results from a T to A substitution at nucleotide position 559, causing the tryptophan (W) at amino acid position 187 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal dominant centronuclear myopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.72
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Pathogenic
0.37
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.67
D
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.52
T
M_CAP
Pathogenic
0.47
D
MetaRNN
Uncertain
0.49
T
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Uncertain
2.7
M
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-4.3
D
REVEL
Pathogenic
0.77
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.86
MutPred
0.49
Gain of disorder (P = 0.0014);
MVP
1.0
MPC
1.6
ClinPred
0.14
T
GERP RS
5.4
Varity_R
0.82
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143677057; hg19: chr12-81102342; API